DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Hilton Washington DC/Rockville Hotel & Executive Meeting Ctr.

2017年9月14日 (木) 午前 7:00 - 2017年9月15日 (金) 午後 3:00

1750 Rockville Pike, , Rockville, MD 20852 , USA

Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

Session 7: Sharing Patient Level Data: Where Are We Headed?

Session Chair(s)

Marla Jo  Brickman, PhD

Marla Jo Brickman, PhD

Senior Director - Clinical Data Transparency/Compassionate Access Lead

Pfizer Inc, United States

The sharing of patient-level data has now become the new norm. Provisions for sponsors of clinical research (industry, academia, government) are being added to regulations and guidelines requiring these sponsors to make the de-identified/anonymized data supporting this clinical research available to other researchers. In this session, we will discuss the practical implications of current data sharing models, as well as, explore future models and what this means for the research community, government, industry, and academia.

Learning Objective :
  • Explain current models for the sharing of patient-level data
  • Recognize proposals for future models for the sharing of patient-level data
  • Interpret first-hand accounts in sharing/using patient-level data
  • Speaker(s)

    Sean  Khozin, MD, MPH

    Speaker

    Sean Khozin, MD, MPH

    CancerLinQ, LLC, United States

    Executive Vice President of ASCO; Chief Executive Officer

    Rebecca  Li, PhD

    Speaker

    Rebecca Li, PhD

    Vivli , United States

    Executive Director, Center for Global Clinical Research Data

      Panel Discussion

    Q&A Panel Discussion

    Panel Discussion

    All Session Speakers, United States

    最新情報や機会を逃さないで

    DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。